World's Best Scientists 2026 revealed!
Dominique Costagliola

Dominique Costagliola

Award Badge
Medicine
France
2023

D-Index & Metrics

Best Female Scientists

D-Index
107
Citations
43463
World Ranking
1013
National Ranking
30

Medicine

D-Index
107
Citations
44690
World Ranking
6216
National Ranking
180

Dominique Costagliola publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Dominique Costagliola sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 715 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Dominique Costagliola D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Dominique Costagliola sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 107 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in France Leader Award

Overview

Dominique Costagliola is affiliated with Inserm in France and has contributed extensively to the field of medicine, particularly focusing on infectious diseases. Their research outputs span a range of topics including HIV/AIDS, COVID-19, and related clinical interventions.

The main fields of study for Dominique Costagliola include Medicine, with significant specialization in the following subfields:

  • Infectious Diseases
  • Epidemiology
  • Virology
  • Neurology
  • Oncology

Key research topics covered in their work are:

  • COVID-19 Clinical Research Studies
  • HIV/AIDS Research and Interventions
  • SARS-CoV-2 and COVID-19 Research
  • HIV Research and Treatment
  • Long-Term Effects of COVID-19
  • HIV, Drug Use, Sexual Risk
  • HIV-related health complications and treatments

Dominique Costagliola is a frequent collaborator with several researchers, including:

  • Lambert Assoumou
  • Florence Ader
  • Maya Hites
  • Karine Lacombe
  • Christine Katlama

Their recent papers demonstrate involvement in major clinical trials and observational studies related to infectious diseases and COVID-19 treatments. Selected publications include:

  • Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial, 2021, The Lancet Infectious Diseases
  • Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study, 2022, The Lancet HIV
  • Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials, 2023, The Lancet Respiratory Medicine
  • Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design, 2024, The Lancet Infectious Diseases
  • An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19, 2021, Clinical Microbiology and Infection

Their work has been published in several prominent venues, with frequent appearances in:

  • SSRN Electronic Journal
  • Clinical Infectious Diseases
  • Journal of Antimicrobial Chemotherapy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • AIDS

Best Publications

  • Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

    Matthias Egger;Margaret May;Geneviève Chene;Andrew N. Phillips

  • Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study.

    Asier Sáez-Cirión;Charline Bacchus;Laurent Hocqueloux;Véronique Avettand-Fenoel

  • Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

    Jonathan A C Sterne;Margaret May;Dominique Costagliola;Frank de Wolf

  • Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover

    Jorge R. Almeida;David A. Price;David A. Price;Laura Papagno;Zaïna Aït Arkoub

  • Causes of death in HIV-1 infected patients treated with antiretroviral therapy 1996-2006: collaborative analysis of 13 HIV cohort studies

    J Gill;Margaret T May;C Lewden;M Saag

  • Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.

    Murielle Mary-Krause;Laurent Cotte;Anne Simon;Maria Partisani

  • Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study

    Marguerite Guiguet;François Boué;Jacques Cadranel;Jean-Marie Lang

  • The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals

    Maile Ray;Roger Logan;Jonathan A C Sterne;Sonia Hernández-Díaz

  • Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

    Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö

  • Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy.

    Sophie Grabar;Vincent Le Moing;Cécile Goujard;Catherine Leport

  • Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS

    Charlotte Lewden;Dominique Salmon;Philippe Morlat;Sibylle Bévilacqua

  • Beyond viral suppression of HIV – the new quality of life frontier

    Jeffrey V. Lazarus;Jeffrey V. Lazarus;Kelly Safreed-Harmon;Simon E. Barton;Dominique Costagliola

  • Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol

    Dominique Salmon-Ceron;Charlotte Lewden;Philippe Morlat;Sibylle Bévilacqua

  • Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

    Caroline Besson;Aicha Goubar;Jean Gabarre;Willy Rozenbaum

  • Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic).

    Charlotte Lewden;Thierry May;Eric Rosenthal;Christine Burty

  • Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA.

    Marc-Antoine Valantin;Camille Aubron-Olivier;Jade Ghosn;Elisabeth Laglenne

  • Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE).

    Amanda Mocroft;Jens D Lundgren;Jens D Lundgren;Miriam Lewis Sabin;Antonella d'Arminio Monforte

  • Incidence of Non–AIDS-Defining Cancers Before and During the Highly Active Antiretroviral Therapy Era in a Cohort of Human Immunodeficiency Virus–Infected Patients

    Magid Herida;Murielle Mary-Krause;Régis Kaphan;Jacques Cadranel

  • Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies.

    May M;Sterne Ja;Sabin C;Costagliola D

  • Impact of Individual Antiretroviral Drugs on the Risk of Myocardial Infarction in Human Immunodeficiency Virus-Infected Patients A Case-Control Study Nested Within the French Hospital Database on HIV ANRS Cohort CO4

    Sylvie Lang;Murielle Mary-Krause;Laurent Cotte;Jacques Gilquin

Frequent Co-Authors

Christine Katlama
Christine Katlama Sorbonne University
Geneviève Chêne
Geneviève Chêne University of Bordeaux
Jonathan A C Sterne
Jonathan A C Sterne University of Bristol
Brigitte Autran
Brigitte Autran Sorbonne University
Dominique Salmon
Dominique Salmon Université Paris Cité
Margaret T May
Margaret T May University of Bristol
Amy C. Justice
Amy C. Justice Yale University
Gilles Peytavin
Gilles Peytavin Claude Bernard University Lyon 1
Philippe Morlat
Philippe Morlat University of Bordeaux
Caroline Sabin
Caroline Sabin University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but seeking flexible or specialized routes, there are a variety of online degree pathways available. Many students opt for advanced nursing degrees, such as the most affordable DNP programs, which open doors to leadership and clinical practice roles without the need to relocate.

Pharmacy is another popular choice, with the emergence of 3 year online PharmD programs that allow working professionals to advance their careers flexibly.

If you are drawn to the technological side of medicine, healthcare informatics degree programs prepare students to manage patient data and healthcare technology—key skills in the modern healthcare system.

For those looking to enter the workforce more quickly, billing and coding classes online can lead to vital administrative roles in medical facilities, often in under a year.

These alternative online career pathways offer flexibility, affordability, and the opportunity to make a difference in healthcare without the traditional medical school route.

Best Scientists Citing Dominique Costagliola

Trending Scientists

Recently Published Articles